Makoto Isono

642 total citations
45 papers, 521 citations indexed

About

Makoto Isono is a scholar working on Molecular Biology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Makoto Isono has authored 45 papers receiving a total of 521 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 14 papers in Surgery and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Makoto Isono's work include Histone Deacetylase Inhibitors Research (8 papers), Renal cell carcinoma treatment (7 papers) and Bladder and Urothelial Cancer Treatments (7 papers). Makoto Isono is often cited by papers focused on Histone Deacetylase Inhibitors Research (8 papers), Renal cell carcinoma treatment (7 papers) and Bladder and Urothelial Cancer Treatments (7 papers). Makoto Isono collaborates with scholars based in Japan, Singapore and Germany. Makoto Isono's co-authors include Akinori Sato, Takako Asano, Tomohiko Asano, Keiichi Ito, Kosuke Miyai, Wolfgang A. Schulz, Martin Michaelis, Günter Niegisch, Maria Pinkerneil and Jindřich Činátl and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Makoto Isono

42 papers receiving 518 citations

Peers

Makoto Isono
Aitor Benedicto Spain
Kristy Kwan‐Shuen Chan Hong Kong
Yan-qing Ding China
Shuzhen Chen China
Leticia Serrano‐Oviedo Spain
Dawei Yang China
Jennifer Y. Lee United States
Masahiro Uehara Japan
Aitor Benedicto Spain
Makoto Isono
Citations per year, relative to Makoto Isono Makoto Isono (= 1×) peers Aitor Benedicto

Countries citing papers authored by Makoto Isono

Since Specialization
Citations

This map shows the geographic impact of Makoto Isono's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Makoto Isono with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Makoto Isono more than expected).

Fields of papers citing papers by Makoto Isono

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Makoto Isono. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Makoto Isono. The network helps show where Makoto Isono may publish in the future.

Co-authorship network of co-authors of Makoto Isono

This figure shows the co-authorship network connecting the top 25 collaborators of Makoto Isono. A scholar is included among the top collaborators of Makoto Isono based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Makoto Isono. Makoto Isono is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Isono, Makoto, et al.. (2021). Inhibition of checkpoint kinase 1 potentiates anticancer activity of gemcitabine in bladder cancer cells. Scientific Reports. 11(1). 10181–10181. 14 indexed citations
2.
Isono, Makoto, Takako Asano, Nina Reßing, et al.. (2021). Ubiquitin-proteasome System Is a Promising Target for Killing Cisplatin-resistant Bladder Cancer Cells. Anticancer Research. 41(6). 2901–2912. 5 indexed citations
3.
Isono, Makoto, et al.. (2019). Metformin Augments Panobinostat's Anti-Bladder Cancer Activity by Activating AMP-Activated Protein Kinase. Translational Oncology. 12(4). 669–682. 19 indexed citations
4.
Isono, Makoto, et al.. (2018). Evaluation of Therapeutic Potential of Phenoxodiol, a Novel Isoflavone Analog, in Renal Cancer Cells. Anticancer Research. 38(10). 5709–5716. 8 indexed citations
5.
Isono, Makoto, et al.. (2018). Panobinostat and Nelfinavir Inhibit Renal Cancer Growth by Inducing Endoplasmic Reticulum Stress. Anticancer Research. 38(10). 5615–5626. 11 indexed citations
6.
Isono, Makoto, et al.. (2018). Delanzomib Interacts with Ritonavir Synergistically to Cause Endoplasmic Reticulum Stress in Renal Cancer Cells. Anticancer Research. 38(6). 3493–3500. 23 indexed citations
7.
Sato, Akinori, et al.. (2018). Nelfinavir Induces Endoplasmic Reticulum Stress and Sensitizes Renal Cancer Cells to TRAIL. Anticancer Research. 38(8). 4505–4514. 13 indexed citations
8.
Sato, Akinori, Keitaro Nakamoto, Yuki Hatanaka, et al.. (2018). Bosniak Category III Renal Cysts Caused by Crizotinib in an Anaplastic Lymphoma Kinase Gene-Rearranged Non–Small Cell Lung Cancer Patient. Urology. 121. e3–e4. 3 indexed citations
9.
Isono, Makoto, Akinori Sato, Fumihiko Kimura, & Tomohiko Asano. (2017). A case of mucosa-associated lymphoid tissue lymphoma of the bladder successfully treated with radiotherapy. Urology Case Reports. 16. 1–3. 4 indexed citations
10.
Isono, Makoto, Michèle J. Hoffmann, Maria Pinkerneil, et al.. (2017). Checkpoint kinase inhibitor AZD7762 strongly sensitises urothelial carcinoma cells to gemcitabine. Journal of Experimental & Clinical Cancer Research. 36(1). 1–1. 74 indexed citations
11.
Isono, Makoto, Keiichi Ito, Takashi Kimura, et al.. (2017). A Case of Hemorrhagic Adrenal Pseudocyst Mimicking Solid Tumor. American Journal of Case Reports. 18. 1034–1038. 6 indexed citations
12.
Horiguchi, Akio, Shinsuke Tasaki, Makoto Isono, et al.. (2017). STAT3 inhibition by WP1066 suppresses the growth and invasiveness of bladder cancer cells. Oncology Reports. 38(4). 2197–2204. 36 indexed citations
13.
14.
Ueda, Yoshihiro, et al.. (2016). Dosimetric Impact of Rotational Setup Errors for Cervical Cancer Patients With Postoperative Volumetric Modulated Arc Therapy. International Journal of Radiation Oncology*Biology*Physics. 96(2). E603–E603.
15.
Yoshimoto, Yuya, Takahiro Oike, Noriyuki Okonogi, et al.. (2015). Carbon-ion beams induce production of an immune mediator protein, high mobility group box 1, at levels comparable with X-ray irradiation. Journal of Radiation Research. 56(3). 509–514. 58 indexed citations
16.
Sato, Akinori, Takako Asano, Makoto Isono, Keiichi Ito, & Tomohiko Asano. (2014). Panobinostat synergizes with bortezomib to induce endoplasmic reticulum stress and ubiquitinated protein accumulation in renal cancer cells. BMC Urology. 14(1). 71–71. 27 indexed citations
17.
Sato, Akinori, Takako Asano, Makoto Isono, Keiichi Ito, & Tomohiko Asano. (2014). Ritonavir acts synergistically with panobinostat to enhance histone acetylation and inhibit renal cancer growth. Molecular and Clinical Oncology. 2(6). 1016–1022. 13 indexed citations
18.
Kuroda, Kenji, Junichi Asakuma, Takako Asano, et al.. (2014). Clinical significance of p21-activated kinase 1 expression level in patients with upper urinary tract urothelial carcinoma. Japanese Journal of Clinical Oncology. 45(1). 103–110. 4 indexed citations
19.
Isono, Makoto, Akio Horiguchi, Shinsuke Tasaki, et al.. (2012). THE EFFICACY OF DIRECT VISION INTERNAL URETHROTOMY FOR MALE URETHRAL STRICTURE. The Japanese Journal of Urology. 103(6). 691–696. 2 indexed citations
20.
Ziyadeh, Fuad N., Makoto Isono, & Sheldon Chen. (2002). Involvement of the transforming growth factor-β system in the pathogenesis of diabetic nephropathy. Clinical and Experimental Nephrology. 6(3). 125–129. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aitor Benedicto Breakdown of academic impact, for papers by Kristy Kwan‐Shuen Chan Breakdown of academic impact, for papers by Yan-qing Ding Breakdown of academic impact, for papers by Shuzhen Chen Breakdown of academic impact, for papers by Leticia Serrano‐Oviedo Breakdown of academic impact, for papers by Dawei Yang Breakdown of academic impact, for papers by Jennifer Y. Lee Breakdown of academic impact, for papers by Masahiro Uehara
Rankless by CCL
2026